INC Research, a provider of clinical research and other life sciences services, is expanding its footprint in Asia.

The Raleigh-based firm has acquired Trident Clinical research, which operates in Australia, New Zealand and India.

Financial terms were not disclosed.

Trident will operate under its existing name as an INC research company.

“Trident is an important piece in our strategy to build a sustainable CRO business that both satisfies and anticipates the global drug development needs of our customers,” said James Ogle, INC Research’s chief executive officer. “Trident has established an exceptional reputation in the region with emerging biotechs to local affiliates of global pharmaceutical companies and major principal investigator units. We are very happy to add them to our team.”

Trident launched in 1997 and has some 100 employees.

Get the latest news alerts: Follow WRAL Tech Wire at Twitter.